Intentar ORO - Gratis

Clinical trials for generics proposed

Financial Express Mumbai

|

October 11, 2025

EVEN AS INDIAN drug-makers have heaved a sigh of relief with the United States' decision to shelve the plan to extend the tariff hikes to generic medicines, a key change is in the offing in domestic regulations that will spell trouble for them.

- MANU KAUSHIK

The country's drug regulator - Central Drugs Standard Control Organisation (CDSCO) - has proposed to close the easy route for pharmaceutical companies to quickly launch generic versions of "new drugs" by just proving that these are bio-equivalent to the innovators' drugs.

Experts said that the move has come in the wake of growing pressure from the Donald Trump administration to reduce the non-tariff barriers for US companies in India.

IF THE PROPOSAL, made in a "note for public comments" released by CDSCO, is converted into a rule, the launch of generic drugs will also require submission of separate data on clinical trials, just as the "new drugs" do. Clinical trials are much more expensive and time-consuming than the bioequivalence studies. Currently, once a new drug is approved based on clinical trials and BE data, the generic companies simultaneously submit the BE study report with the regulator, and obtain approval for their version of the drug.

However, this puts the innovator company at a disadvantageous position as there is a lack of level-playing field, the CDSCO said in the note.

MÁS HISTORIAS DE Financial Express Mumbai

Financial Express Mumbai

GOVT'S INFRA PUSH Nod to ₹1 L cr urban fund, ₹10,000-cr startup boost

THE UNION CABINET has approved the launch of the Urban Challenge Fund (UCF) with a total central assistance of ₹1 lakh crore, expected to leverage ₹4 lakh crore in investments across India's cities over five years under a market-linked programme.

time to read

2 mins

February 15, 2026

Financial Express Mumbai

Cinema to OTT, Indian audiences slayed by anime

Platforms ramp up content as fandom increases

time to read

3 mins

February 15, 2026

Financial Express Mumbai

Our interests foremost in foreign policy: Rahman

IN HIS FIRST remarks since winning the elections with a landslide majority, Bangladesh Nationalist Party (BNP) chief Tarique Rahman, who is tipped to become the Prime Minister, underlined Saturday that he would keep in mind the \"interests of Bangladesh\" and \"protecting the interests of the people of the country\" while deciding his foreign policy.

time to read

1 mins

February 15, 2026

Financial Express Mumbai

Global honchos to get a taste of desi technology

UPI, DigiYatra, dark stores to anchor operations

time to read

1 mins

February 15, 2026

Financial Express Mumbai

FM: India climate action funding is 5.6% of GDP

FINANCE MINISTER NIRMALA Sitharaman on Saturday said India has hiked spending on climate action in the last six years to 5.6% of GDP, demonstrating the country's pursuit of meeting nationally determined goals on curbing carbon emission.

time to read

1 min

February 15, 2026

Financial Express Mumbai

Goyal: India-US interim trade pact to cover energy needs

UNION MINISTER PIYUSH Goyal on Saturday said the interim trade agreement reached between the Centre and the US will include India's energy requirements and would help it secure crude oil at more competitive prices.

time to read

1 min

February 15, 2026

Financial Express Mumbai

Manappuram Finance gets RBI nod for Bain Capital joint control

MANAPPURAM FINANCE HAS received the Reserve Bank of India’s (RBI) final approval for the proposed acquisition of joint control and 41.66% shareholding in the company’s paid-up equity capital and convertible instruments by Bain Capital.

time to read

1 min

February 15, 2026

Financial Express Mumbai

Democracy, North Korea style

WHEN I READ in this newspaper last week that the dictator of North Korea has decided to make his teenage daughter his official heir, it made me laugh.

time to read

3 mins

February 15, 2026

Financial Express Mumbai

US audacity, not reciprocity

The MEA states that the India-US joint statement remains the framework for the proposed interim agreement on reciprocal and mutually beneficial trade, and both sides will work toward finalising the agreement

time to read

3 mins

February 15, 2026

Financial Express Mumbai

Am I human?

Amid evolving technologies, artists are reimagining what it means to be alive today

time to read

5 mins

February 15, 2026

Listen

Translate

Share

-
+

Change font size